𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Complications associated with indwelling catheters

✍ Scribed by Simmons, Jeané R. ;Buzdar, Aman U. ;Ota, David M. ;Marts, Kathy ;Hortobagyi, Gabriel N.


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
340 KB
Volume
20
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Between 1983 and 1985, 170 consecutive patients received doxorubicin‐containing adjuvant chemotherapy through central venous catheters, and four via a long indwelling catheter in the antecubital fossa. The objective of this retrospective study is to determine the acute and chronic complications associated with indwelling catheters. Ninety‐four (56%) patients did not experience any complications. The incidence of acute complications was 2%, which included three pneumothorax. Twenty‐nine (17%) patients experienced chronic complications. Of those, 20 (12%) developed infectious complications, and 9 (19%) developed thrombus. In addition, 12 (7%) developed multiple complications, and 32 (19%) patients had other local complications at the catheter site, which included allergic reactions and catheter breakage. Each of these complications was resolved with appropriate treatment. None of the patients died from complications of the indwelling catheter.


📜 SIMILAR VOLUMES


Letter to the Editor: “Atrial thrombi as
✍ Burke, G.A. A.; Walker, D. A.; Hewitt, M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 12 KB 👁 2 views

Central venous catheters (CVC's) placed to access the venous system are routinely used in the intensive care of children requiring prolonged intravenous therapy for cancer. The use of such catheters are justified particularly in young children to reduce the number of painful procedures and facilitat

A new complication of chemotherapy admin
✍ Bach Ardalan; M. Regina Flores 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Background. The use of permanent intravenous access devices for chemotherapy administration has become a common practice in clinical oncology. Therefore, awareness of potential complications is important. The authors previously reported the use of high dose 5-fluorouracil(5-FU) (2600 mg/m2) and leuc